Military Veterans May Be Developing More Zantac Cancer Than The General Population

Veterans have been filing suit to claim compensation for developing Zantac cancer.

Tuesday, November 17, 2020 - While not on the scale equivalent to Agent Orange cancer or defective combat earplugs, military veterans are experiencing health difficulties such as developing cancer allegedly from using heartburn and acid reflux medicine Zantac regularly and for many years. Soldiers prescribed Protein Pump Inhibitors (Nexium and Prilosec) and H2 Histamine Blocker (Zantac) to treat heartburn and acid reflux conditions are blaming ranitidine for causing cancer. Many veterans are filing suit against Sanofi, the maker of Zantac, for failing to warn them that ranitidine contains elevated levels of NDMA, a carcinogen found in the air, water, and land in and around industrial manufacturing plants. Experts have narrowed down the source of NDMA contamination to storing drugs at high temperatures, how the drug interacts with stomach contents like processed meats, and also from being contaminated at manufacturing plants overseas. Zantac stomach cancer lawsuit lawyers offer a free no obligation consultation before filing a lawsuit claim.

Hundreds of lawsuits by former Zantac users allege that Sanofi failed to warn them of cancerous levels of NDMA in each Zantac tablet they used. Heartburn medicine is one of the most frequently requested by US Military personnel, according to the Veteran's Association Blog. Most had been taking PPI drugs but then switched to Zantac for various reasons. In general, veterans appear to be more apt to suffer from heartburn, acid reflux, and gastroesophageal reflux disease (GERD) than the general civilian population. According to Consumer Notice.org, "some studies show that veterans with post-traumatic stress disorder (PTSD) often have gastroesophageal reflux disorder (GERD), acid reflux and irritable bowel syndrome (IBS), according to Dr. Jaimie L. Gradus of the National Center for PTSD, VA Boston Healthcare System and colleagues published in Epidemiology. Drugs for GI problems include proton pump inhibitors (PPIs) such as Nexium and Prilosec or H2 blockers such as Zantac."

Soldier's cancer complaints mirror others that have been made. Zantac has been alleged to contribute to stomach cancer, bladder, esophageal, colon, prostate, and many other forms of cancer. Sanofi immediately recalled Zantac in 2019 when scientists discovered elevated levels of NDMA in their tablets. The US Food and Drug Administration followed several months later by pulling all ranitidine products from store shelves. Health experts accuse the Veteran's Administration of over-prescribing heartburn and GERD medicines and programs have been put into place to reduce the practice. According to the VA blog, "PPIs account for more than 11 million 30-day prescriptions each year in VA. The drugs are inexpensive on a per-pill basis. However, their widespread use translates into $50 million in VA annually. Current research suggests patients could stop or reduce the use of the drugs in more than one-third of the cases."

If you or a loved one have been prescribed Zantac or other brand of ranitidine and have used it regularly for decades, and developed cancer, you should speak with a Heartburn Medicine Cancer lawyer to see if you qualify for lump-sum compensation which could be in addition to military disability income and other benefits.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.